New pill shows promise for severe eczema in major trial
NCT ID NCT05526222
First seen Jan 06, 2026 · Last updated May 15, 2026 · Updated 25 times
Summary
This study tests an experimental pill called jaktinib for adults with moderate to severe atopic dermatitis (eczema). About 443 participants will receive either the drug or a placebo to see if it improves skin symptoms like redness and itching. The goal is to find a new treatment option for people whose eczema is not well controlled.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
139 People's Middle Road
Changsha, Hunan, 410008, China
Conditions
Explore the condition pages connected to this study.